share_log

Evercore ISI Group Maintains In-Line on Augmedix, Lowers Price Target to $4.5

Benzinga ·  Mar 19 11:28

Evercore ISI Group analyst Elizabeth Anderson maintains Augmedix (NASDAQ:AUGX) with a In-Line and lowers the price target from $6.5 to $4.5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment